Scope eKnowledge Center Ltd. Research Reports

Title	Published	Price
Biofuels-A Second Generation Biofuel Feedstock By: Scope eKnowledge Center Ltd. This research report by Scope e-Knowledge Center titled “Switchgrass-A Second Generation Biofuel Feedstock” delves into the current status of research and commercialization of biofuel production based on switchgrass. Switchgrass, a perennial grass variety, produces about \| more... Search inside this report	10/20/2009	$1,500.00
Solar Photovoltaic Cells (SPVC) Industry - A Market & IP Perspective By: Scope eKnowledge Center Ltd. Rising energy and oil prices in light of the economic slowdown, and a heightened awareness of the environment, have led to an increase in global incentives for the diversification of energy sources and greater utilization \| more... Search inside this report	6/1/2009	$5,000.00
Asian Insurance Focus: India & China By: Scope eKnowledge Center Ltd. Globalization is the key source which is bringing about an "irreversible transformation" in the Asian insurance market. India and China are "dynamically" driving the growth of insurance markets in Asia and the outlook for this \| more...	8/1/2008	$3,000.00
Clinical Research Outsourcing and India By: Scope eKnowledge Center Ltd. A Clinical research (CR) organization is one that manages a research or an investigation to assess and/or verify the clinical, pharmacological or other pharmacodynamic effects, safety and/or efficacy and adverse reactions of an investigational product. \| more... Search inside this report	6/1/2006	$1,000.00
Watson Pharmaceuticals Inc. By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Vivus Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
United Therapeutics Corporation By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Teva Pharmaceuticals Industries Ltd. By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Savient Pharmaceuticals Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Pharmaceutical Product Development, Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Pacific Health Systems Inc. By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Orphan Medical Inc. By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Kendle International Inc. By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Inkine Pharmaceutical Company Inc. By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Icon Plc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Hi-Tech Pharmacal, Co. Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Cytogen Corporation By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
C V Therapeutics Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Curative Health Services Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Columbia Laboratories Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
CollaGenex Pharmaceuticals Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Barr Pharmaceuticals Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Arena Pharmaceuticals Inc By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Acambis PLC By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	9/1/2004	$375.00
Wyeth By: Scope eKnowledge Center Ltd. Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value \| more... Search inside this report	8/1/2004	$375.00
Title	Published	Price

< prev 1 2 3 4 5 next >

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 3